Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Renovaro Biosciences ( (RENB) ) just unveiled an announcement.
On September 2, 2025, the Court of Amsterdam declared Gedi Cube B.V., an indirect subsidiary of Lunai Bioworks, Inc., bankrupt due to its inability to meet financial obligations. This development has led to a material impairment of assets for the company, which will be recorded in the quarter ending September 30, 2025. The company is assessing the impact on its supply chain and customer relationships and is implementing contingency plans to mitigate business disruptions. Lunai and its other subsidiaries continue to operate normally, with no bankruptcy filings.
More about Renovaro Biosciences
Average Trading Volume: 2,062,893
Technical Sentiment Signal: Strong Sell
Current Market Cap: $49.28M
For detailed information about RENB stock, go to TipRanks’ Stock Analysis page.